2013 parkinson's disease glutathione four authors doi Potential use of as a treatment for Parkinson's disease-specific α-Synuclein variants potentially
Parkinson's disease specific Synuclein variants potentially drive Lewy body formation by engaging in promiscuous and non functional interactions Communications Biology Implications for the role of natural products in Parkinson disease therapy Frontiers Neurodegenerative disease and antioxidant biomarkers: A bidirectional Mendelian randomization study Early diagnosis of Parkinson's disease: biomarker study Frontiers
Pay in 4 interest-free payments of $5.13 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Sep 16 - Sep 21



